Cuproptosis-a potential target for the treatment of osteoporosis DOI Creative Commons

Dinglin Li,

Zhonghua Gao,

Qian Li

и другие.

Frontiers in Endocrinology, Год журнала: 2023, Номер 14

Опубликована: Май 5, 2023

Osteoporosis is an age-related disease of bone metabolism marked by reduced mineral density and impaired strength. The causes the bones to weaken break more easily. Osteoclasts participate in resorption than osteoblasts formation, disrupting homeostasis leading osteoporosis. Currently, drug therapy for osteoporosis includes calcium supplements, vitamin D, parathyroid hormone, estrogen, calcitonin, bisphosphates, other medications. These medications are effective treating but have side effects. Copper a necessary trace element human body, studies shown that it links development Cuproptosis recently proposed new type cell death. Copper-induced death regulates lipoylated components mediated via mitochondrial ferredoxin 1; is, copper binds directly tricarboxylic acid cycle, resulting protein accumulation subsequent loss iron-sulfur cluster proteins, proteotoxic stress eventually Therapeutic options tumor disorders include targeting intracellular toxicity cuproptosis. hypoxic environment metabolic pathway glycolysis provide energy cells can inhibit cuproptosis, which may promote survival proliferation various cells, including osteoblasts, osteoclasts, effector T macrophages, thereby mediating process. As result, our group tried explain relationship between role cuproptosis its essential regulatory genes, as well pathological mechanism effects on cells. This study intends investigate treatment approach clinical beneficial

Язык: Английский

Lifestyle Management in Menopause: A Systematic Review of Women With Premature Ovarian Insufficiency DOI Creative Commons
Ladan Yeganeh, Nathalie Vermeulen, Carolyn Ee

и другие.

Clinical Endocrinology, Год журнала: 2025, Номер unknown

Опубликована: Фев. 24, 2025

ABSTRACT Objective Premature ovarian insufficiency (POI), the loss of function before age 40, increases risk cardiovascular disease, low bone mineral density, dementia and psychological distress. Lifestyle interventions reduce chronic disease in other populations and, with hormone therapy, may improve health outcomes POI. This review aims to identify role lifestyle, including diet physical activity, managing symptoms, improving quality life (QoL) preventing women The findings this informed 2024 update ESHRE Evidence‐Based POI Guideline. Design A systematic search was conducted PubMed Medline databases from January 2014 February 2024. included randomized controlled trials quasi‐experimental that examined impact lifestyle on Outcomes menopause QoL, health. Risk bias assessed using Joanna Briggs Institute critical appraisal tool. Results literature yielded 890 citations, one study meeting inclusion criteria. Two additional studies guideline chapter searches were included, totalling three articles. involved cancer survivors those Turner syndrome. Limited evidence suggests interventions, particularly density effect dietary supplementation mixed. Conclusions While a healthy is proven prevent diseases QoL postmenopausal women, there limited specific Targeted are needed determine most effective for addressing their heightened risks unmet needs.

Язык: Английский

Процитировано

1

Association between serum uric acid levels and bone mineral density in Chinese and American: a cross-sectional study DOI Creative Commons

Xingzhi Li,

Wei Peng Yong, Kexin Chen

и другие.

Scientific Reports, Год журнала: 2025, Номер 15(1)

Опубликована: Март 10, 2025

Despite extensive studies conducted on the relationship between serum uric acid (UA) and bone mineral density (BMD), their association remains controversial. In this study, we investigated whether UA levels are independently associated with BMD in Chinese American populations to elucidate association. Herein, data of 12,344 individuals (age > 20 years) from National Health Nutrition Examination Survey (2005–2018) those 768 inpatient medical records physical examination center systems Tertiary Class A Hospital (2021–2023) China were included. The was analyzed by employing multivariate regression models covariate adjustments. addition, population description, stratified analysis, single-factor smooth-curve fitting, threshold saturation effect analyses performed. After adjustments, exhibited an femur (β = 0.008, 95% confidence interval [CI] 0.001–0.015, P 0.02), femoral neck 0.011, CI 0.004–0.018, 0.002), lumbar spine 0.014, 0.06–0.022, < 0.001) subjects. Similarly, 0.079, 0.042–0.117, 0.001), 0.171, 0.121–0.22, 0.052, 0.007–0.097, 0.024) Notably, nonlinear. saturated utility values for determining level using a two-stage linear model 429.9 468 μmol/L, respectively, population. population, femur, neck, 410.4, 452 respectively. Altogether, present findings suggested positive overall adults, implying that maintaining can facilitate osteoporosis prevention. Clinical Trials Registry: MR-51-23-051741. https://www.medicalresearch.org.cn/search/research/researchViewid=c0e5f868-eca9-4c68-af58-d73460c34028 .

Язык: Английский

Процитировано

1

Melatonin alleviates hydrogen peroxide induced oxidative damage in MC3T3-E1 cells and promotes osteogenesis by activating SIRT1 DOI
Hedong Liu, Maoxian Ren, Yang Li

и другие.

Free Radical Research, Год журнала: 2022, Номер 56(1), С. 63 - 76

Опубликована: Янв. 2, 2022

Oxidative stress is an important contributor to the development of osteoporosis. Melatonin, indoleamine secreted by pineal gland, has antioxidant properties. This study aims explore whether melatonin can promote bone formation and elucidate mechanisms underlying this process. In study, we used in vitro hydrogen peroxide (H2O2)-induced oxidative model MC3T3-E1 cells vivo ovariectomized osteoporotic defect rats protective effects against defects along with mechanism these effects. We found that significantly increased alkaline phosphatase activity, mineralization capacity, expression BMP2, RUNX2, OPN treated H2O2. Furthermore, was activate SIRT1, SIRT3 inhibit p66Shc, reduce intracellular reactive oxygen species levels, stabilize mitochondria, malondialdehyde increase superoxide dismutase apoptosis Intriguingly, could be reversed SIRT1 inhibitor EX527. experiments confirmed improves microstructure mineral density distal femoral trabecula promotes formation. Meanwhile, activated inhibited p66Shc expression. Taken together, our findings showed restrain damage osteogenesis activating which regulate activity suggesting a potential therapeutic agent for osteoporosis-related metabolic diseases.

Язык: Английский

Процитировано

30

Polyphenols as potential preventers of osteoporosis: A comprehensive review on antioxidant and anti-inflammatory effects, molecular mechanisms, and signal pathways in bone metabolism DOI Open Access

Zhan Su,

Bin Yao,

Gang Liu

и другие.

The Journal of Nutritional Biochemistry, Год журнала: 2023, Номер 123, С. 109488 - 109488

Опубликована: Окт. 20, 2023

Язык: Английский

Процитировано

20

Cuproptosis-a potential target for the treatment of osteoporosis DOI Creative Commons

Dinglin Li,

Zhonghua Gao,

Qian Li

и другие.

Frontiers in Endocrinology, Год журнала: 2023, Номер 14

Опубликована: Май 5, 2023

Osteoporosis is an age-related disease of bone metabolism marked by reduced mineral density and impaired strength. The causes the bones to weaken break more easily. Osteoclasts participate in resorption than osteoblasts formation, disrupting homeostasis leading osteoporosis. Currently, drug therapy for osteoporosis includes calcium supplements, vitamin D, parathyroid hormone, estrogen, calcitonin, bisphosphates, other medications. These medications are effective treating but have side effects. Copper a necessary trace element human body, studies shown that it links development Cuproptosis recently proposed new type cell death. Copper-induced death regulates lipoylated components mediated via mitochondrial ferredoxin 1; is, copper binds directly tricarboxylic acid cycle, resulting protein accumulation subsequent loss iron-sulfur cluster proteins, proteotoxic stress eventually Therapeutic options tumor disorders include targeting intracellular toxicity cuproptosis. hypoxic environment metabolic pathway glycolysis provide energy cells can inhibit cuproptosis, which may promote survival proliferation various cells, including osteoblasts, osteoclasts, effector T macrophages, thereby mediating process. As result, our group tried explain relationship between role cuproptosis its essential regulatory genes, as well pathological mechanism effects on cells. This study intends investigate treatment approach clinical beneficial

Язык: Английский

Процитировано

18